Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 4
2017 8
2018 3
2019 5
2020 5
2021 1
2022 12
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance.
Klümper N, Ralser DJ, Ellinger J, Roghmann F, Albrecht J, Below E, Alajati A, Sikic D, Breyer J, Bolenz C, Zengerling F, Erben P, Schwamborn K, Wirtz RM, Horn T, Nagy D, Toma M, Kristiansen G, Büttner T, Hahn O, Grünwald V, Darr C, Erne E, Rausch S, Bedke J, Schlack K, Abbas M, Zschäbitz S, Schwab C, Mustea A, Adam P, Manseck A, Wullich B, Ritter M, Hartmann A, Gschwend J, Weichert W, Erlmeier F, Hölzel M, Eckstein M. Klümper N, et al. Among authors: erlmeier f. Clin Cancer Res. 2023 Apr 14;29(8):1496-1505. doi: 10.1158/1078-0432.CCR-22-1764. Clin Cancer Res. 2023. PMID: 36534531 Free PMC article.
Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution.
Cox A, Klümper N, Stein J, Sikic D, Breyer J, Bolenz C, Roghmann F, Erben P, Wirtz RM, Wullich B, Ritter M, Hölzel M, Schwamborn K, Horn T, Gschwend J, Hartmann A, Weichert W, Erlmeier F, Eckstein M. Cox A, et al. Among authors: erlmeier f. Eur Urol. 2024 Apr;85(4):328-332. doi: 10.1016/j.eururo.2023.03.020. Epub 2023 Apr 6. Eur Urol. 2024. PMID: 37031005 Free article.
cMET: a prognostic marker in papillary renal cell carcinoma?
Erlmeier F, Bruecher B, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Mondorf Y, Ivanyi P, Mikuteit M, Steffens S; German Network Of Kidney Cancer. Erlmeier F, et al. Hum Pathol. 2022 Mar;121:1-10. doi: 10.1016/j.humpath.2021.12.007. Epub 2022 Jan 6. Hum Pathol. 2022. PMID: 34998840
Growth Arrest-Specific 6 in Chromophobe Renal Cell Carcinoma.
Mikuteit M, Zschäbitz S, Erlmeier M, Autenrieth M, Weichert W, Hartmann A, Steffens S, Erlmeier F. Mikuteit M, et al. Among authors: erlmeier f. Oncology. 2022;100(10):536-541. doi: 10.1159/000525601. Epub 2022 Jun 27. Oncology. 2022. PMID: 35760058 Free PMC article.
c-Met in chromophobe renal cell carcinoma.
Erlmeier F, Ivanyi P, Hartmann A, Autenrieth M, Wiedemann M, Weichert W, Steffens S. Erlmeier F, et al. Med Oncol. 2017 Feb;34(2):15. doi: 10.1007/s12032-016-0874-1. Epub 2016 Dec 29. Med Oncol. 2017. PMID: 28035577
Expression of nectin-4 in papillary renal cell carcinoma.
Zschäbitz S, Mikuteit M, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Duensing S, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Erlmeier F, Steffens S. Zschäbitz S, et al. Among authors: erlmeier f. Discov Oncol. 2022 Sep 22;13(1):90. doi: 10.1007/s12672-022-00558-2. Discov Oncol. 2022. PMID: 36136143 Free PMC article.
The Prognostic Impact of PD-L2 in Papillary Renal-Cell Carcinoma.
Mondorf Y, Mikuteit M, Ivanyi P, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief CG, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Steffens S, Erlmeier F. Mondorf Y, et al. Among authors: erlmeier f. Urol Int. 2022;106(11):1168-1176. doi: 10.1159/000525016. Epub 2022 Jun 2. Urol Int. 2022. PMID: 35654002
The role of claudin-6 in chromophobe renal cell carcinoma.
Erlmeier F, Zschäbitz S, Mikuteit M, Autenrieth M, Weichert W, Hartmann A, Steffens S. Erlmeier F, et al. Histol Histopathol. 2023 Apr;38(4):403-407. doi: 10.14670/HH-18-520. Epub 2022 Sep 21. Histol Histopathol. 2023. PMID: 36128931
The synergism of spatial metabolomics and morphometry improves machine learning-based renal tumour subtype classification.
Prade VM, Sun N, Shen J, Feuchtinger A, Kunzke T, Buck A, Schraml P, Moch H, Schwamborn K, Autenrieth M, Gschwend JE, Erlmeier F, Hartmann A, Walch A. Prade VM, et al. Among authors: erlmeier f. Clin Transl Med. 2022 Feb;12(2):e666. doi: 10.1002/ctm2.666. Clin Transl Med. 2022. PMID: 35184396 Free PMC article. No abstract available.
40 results